Interventional Trial of Subconjunctival Bevacizumab in Recurrent Pterygium
Interventional Trial of Subconjunctival Bevacizumab in Recurrent Pterygium
A study to research whether subconjunctival bevacizumab injection may potentially suppress neovascularization in pterygium, retarding and decreasing the size of recurrent pterygium.
Inclusion Criteria:
Exclusion Criteria: